Cresemba and Cell death - a phase IV clinical study of FDA data

Summary:

Cell death is reported as a side effect among people who take Cresemba (isavuconazonium sulfate), especially for people who are male, 20-29 old, also take Foscavir, and have Acute lymphocytic leukemia (all).

The study is created by eHealthMe based on reports of 2,573 people who have side effects when taking Cresemba from the FDA, and is updated regularly.

What is Cresemba?

Cresemba has active ingredients of isavuconazonium sulfate. eHealthMe is studying from 2,574 Cresemba users. Check the latest studies of Cresemba.

On Jul, 14, 2026

2,573 people reported to have side effects when taking Cresemba.
Among them, 19 people (0.74%) died.

Among these 19 people:

What is the gender of people who died when taking Cresemba? *

female: 0.0 %
male: 100 %

What is the age of people who died when taking Cresemba? *

What are other drugs people take besides Cresemba? *

Foscavir: 19 people, 100.00%
Vancomycin: 10 people, 52.63%
Piperacillin And Tazobactam: 4 people, 21.05%

What are other side effects people have before they died? *

Gamma-Glutamyltransferase Increased: 19 people, 100.00%
Blood Bilirubin Increased: 19 people, 100.00%
Blood Alkaline Phosphatase Increased: 19 people, 100.00%
Death: 1 person, 5.26%

What are the existing conditions these people have? *

Mucormycosis (a rare infection caused by organisms that belong to a group of fungi called mucoromycotina): 19 people, 100.00%
Herpes Simplex (herpes simplex is a common viral infection): 19 people, 100.00%
Acute Lymphocytic Leukemia (All) (cancer of the white blood cells characterized by excess lymphoblasts): 19 people, 100.00%

* Approximation only. Some reports may have incomplete information.

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Cresemba:

Cresemba (2,574 reports)

Expand to all the drugs that have ingredients of isavuconazonium sulfate:

Cell death and drugs with ingredients of isavuconazonium sulfate

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Cresemba:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Cell death:

Cell death (211 drugs)

Browse all the conditions that are associated with Cell death:

Cell death (331 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on isavuconazonium sulfate (the active ingredients of Cresemba) and Cresemba (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.